# Magnetic Seizure Therapy (MST) for Severe Mood Disorder

> **NCT00488748** · PHASE3 · COMPLETED · sponsor: **Sarah Lisanby** · enrollment: 75 (actual)

## Conditions studied

- Depression

## Interventions

- **DEVICE:** Thymatron
- **DEVICE:** Magstim Theta

## Key facts

- **NCT ID:** NCT00488748
- **Lead sponsor:** Sarah Lisanby
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2015-01-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00488748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00488748, "Magnetic Seizure Therapy (MST) for Severe Mood Disorder". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00488748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*